Psomagen, Inc. (KOSDAQ:950200)
South Korea · Delayed Price · Currency is KRW 3,105.00
0.00 (0.00%)
At close: May 18, 2026
Psomagen Market Cap
Psomagen has a market cap or net worth of 59.73 billion as of May 19, 2026. Its market cap has decreased by -9.21% in one year.
Market Cap
59.73B
Enterprise Value
59.26B
Revenue
59.19B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,105.00
Market Cap Chart
Since July 13, 2020, Psomagen's market cap has decreased from 254.61B to 59.73B, a decrease of -76.54%. That is a compound annual growth rate of -21.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 59.73B | -19.97% |
| Dec 30, 2025 | 74.64B | -4.20% |
| Dec 30, 2024 | 77.91B | -20.59% |
| Dec 28, 2023 | 98.10B | -34.17% |
| Dec 29, 2022 | 149.03B | -12.38% |
| Dec 30, 2021 | 170.10B | -50.35% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 75.62B |
| Shaperon | 73.02B |
| IMGT Co.,Ltd. | 69.07B |
| Quratis | 66.19B |
| EyeGene | 63.98B |
| Progen | 63.65B |
| HLB Pep | 61.34B |
| J2KBIO | 59.24B |